Core Insights - The Chemours Company is a leading global provider of performance chemicals, with a diverse portfolio that includes titanium technologies, thermal and specialized solutions, advanced performance materials, and chemical solutions [1] - The company serves a global customer base across various sectors, including coatings, plastics, electronics, transportation, and industrial manufacturing [2] - Chemours has seen a significant decline in its stock price, down 32% over the past year, compared to the S&P 500's 16% gain [3] Financial Performance - In the third quarter, Chemours generated $1.5 billion in revenue, which was flat year over year, but achieved a net income of $60 million, recovering from a $32 million loss a year earlier [7] - Adjusted EBITDA for the quarter was $195 million, and free cash flow reached $105 million, reflecting a 54% conversion rate [7] - The strength in Thermal and Specialized Solutions, particularly with Opteon refrigerant sales increasing by 80%, helped mitigate weaknesses in titanium dioxide and advanced materials [7] Investment Activity - Alta Fundamental Advisers established a new position in Chemours during the third quarter, acquiring 800,000 shares valued at approximately $12.67 million [4][5] - This new stake represents 5.41% of Alta's reported U.S. equity assets under management and is the fund's fifth-largest position out of 20 total holdings [3][4] - The investment indicates a strategic move by Alta, as it reflects a willingness to invest in a company that is otherwise facing challenges in the market [6]